DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Sarcosine is an investigational drug.
There have been 14 clinical trials for Sarcosine. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2012.
The most common disease conditions in clinical trials are Schizophrenia, Psychotic Disorders, and Mental Disorders. The leading clinical trial sponsors are China Medical University Hospital, National Science Council, Taiwan, and University of Aarhus.
There is one US patent protecting this investigational drug and eighteen international patents.
Recent Clinical Trials for Sarcosine
|Effect of Obeticholic Acid on Transport of Bile Acids in PBC Examined by 11C-cholyl-sarcosine PET/CT||University of Aarhus||Early Phase 1|
|Carbon-11 Labeled Sarcosine in Prostate Cancer||National Cancer Institute (NCI)||N/A|
|Carbon-11 Labeled Sarcosine in Prostate Cancer||National Institutes of Health (NIH)||N/A|
Top disease conditions for Sarcosine
Top clinical trial sponsors for Sarcosine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Sarcosine||Start Trial||Di- or tripeptide renin inhibitors containing lactam conformational restriction in Achpa||Merck & Co., Inc. (Rahway, NJ)||Start Trial|
|Sarcosine||Start Trial||Delivery system||Alza Corporation (Palo Alto, CA)||Start Trial|
|Sarcosine||Start Trial||Method and articles employing ion exchange material||Raychem Corporation (Menlo Park, CA)||Start Trial|
|Sarcosine||Start Trial||Treatment of hypertension with 1,2,4-angiotensin II antagonists||E. I. Du Pont de Nemours and Company (Wilmington, DE)||Start Trial|
|Sarcosine||Start Trial||Method for dyeing polyester-containing fibers in an alkaline dyeing bath and dyeing assistant, an amino-acid compound||Mitsubishi Kasei Corporation (Tokyo, JP)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Sarcosine||European Patent Office||0312291||2007-10-14||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|